FIELD: chemistry.
SUBSTANCE: present invention concerns new piperidinyl compounds of the formula (I) and (II) which are selectively binding integrine receptors, pharmaceutical compositions and application of the compositions for obtaining medication with antagonistic effect on integrine receptors, where W, R2, Z and q are described in the claim.
EFFECT: pharmaceutical composition for obtaining medication with antagonistic effect on integrine receptors.
33 cl, 1 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
APELIN RECEPTOR AGONISTS (APJ) AND USE THEREOF | 2015 |
|
RU2705800C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
WATER-SOLUBLE ANALOGUES CC-1065 AND THEIR CONJUGATES | 2007 |
|
RU2489423C2 |
PRODRUGS OF THROMBIN INHIBITORS | 1996 |
|
RU2176644C2 |
4-HYDROXY-3-QUINOLINECARBOXAMIDES AND HYDRAZIDES, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD BASED ON THEREOF | 1998 |
|
RU2220960C2 |
PIPERIDINE DERIVATIVES AS MODULATORS OF ACTIVITY OF CCR5 RECEPTOR, METHOD AND INTERMEDIATE COMPOUNDS FOR OBTAINING THEM, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2002 |
|
RU2345990C2 |
INDAZOLE-CARBOXAMIDE COMPOUNDS | 2005 |
|
RU2404179C2 |
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | 2017 |
|
RU2759678C2 |
METHOD FOR PROPAGATION OF DIFFERENTIATION OF PLURIPOTENT CELLS | 2009 |
|
RU2528764C2 |
3,7-DIAZABICYCLO[3.3.0]OCTANES AND THEIR USING IN TREATMENT OF CARDIAC ARRHYTHMIA | 2002 |
|
RU2293085C2 |
Authors
Dates
2008-09-10—Published
2003-08-15—Filed